Becker's Clinical Quality & Infection Control

May / June 2016 Issue of Becker's Infection Control and Clinical Quality

Issue link: https://beckershealthcare.uberflip.com/i/683043

Contents of this Issue

Navigation

Page 34 of 71

ANTISEPTIC IN. ANTIBIOTICS OUT. Introducing Nasal Antiseptic Swabs from Clorox Healthcare ® . A better alternative for nasal decolonization. *"Risk" refers to growing evidence of resistance of S. aureus and MRSA to mupirocin; "complexity" refers to the 5-day, twice-daily application protocol of mupirocin. 1. Clorox Study #9550-005 (in vitro study) 2. Clorox Study #2015-002/2015-003 © 2016 Clorox Professional Products Company, 1221 Broadway, Oakland, CA 94612. NI-32631 Why use antibiotics when you don't have to? Now you can decolonize the nose without the risk and complexity of antibiotics.* • No evidence of bacterial resistance with povidone-iodine • Enhances patient compliance • Reduces 99.4% of S. aureus in 1 hour and maintains persistence for 12 hours 1 • Clinically proven to be non-irritating 2 • Simple and easy to use Order your free sample at cloroxhealthcare.com/NasalAntisepticSwabs.

Articles in this issue

Links on this page

view archives of Becker's Clinical Quality & Infection Control - May / June 2016 Issue of Becker's Infection Control and Clinical Quality